SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4ui9'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HWI_B_115B1_2
(HMG-COA REDUCTASE)
4ui9 CELL DIVISION CYCLE
PROTEIN 23 HOMOLOG

(Homo
sapiens)
4 / 8 SER C 262
VAL C 266
SER C 267
ASN C 299
None
1.05A 1hwiB-4ui9C:
undetectable
1hwiB-4ui9C:
22.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HWK_A_117A2_1
(HMG-COA REDUCTASE)
4ui9 CELL DIVISION CYCLE
PROTEIN 23 HOMOLOG

(Homo
sapiens)
4 / 8 SER C 262
VAL C 266
SER C 267
ASN C 299
None
1.05A 1hwkA-4ui9C:
undetectable
1hwkA-4ui9C:
22.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HWK_C_117C4_1
(HMG-COA REDUCTASE)
4ui9 CELL DIVISION CYCLE
PROTEIN 23 HOMOLOG

(Homo
sapiens)
4 / 8 SER C 262
VAL C 266
SER C 267
ASN C 299
None
1.03A 1hwkC-4ui9C:
undetectable
1hwkC-4ui9C:
22.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HWK_D_117D3_2
(HMG-COA REDUCTASE)
4ui9 CELL DIVISION CYCLE
PROTEIN 23 HOMOLOG

(Homo
sapiens)
4 / 8 SER C 262
VAL C 266
SER C 267
ASN C 299
None
1.03A 1hwkD-4ui9C:
undetectable
1hwkD-4ui9C:
22.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MAA_A_DMEA998_1
(ACETYLCHOLINESTERASE)
4ui9 ANAPHASE-PROMOTING
COMPLEX SUBUNIT 13
CELL DIVISION CYCLE
PROTEIN 23 HOMOLOG

(Homo
sapiens)
5 / 12 ASP M  22
GLU M  27
SER C 317
TYR C 341
TYR C 353
None
1.48A 1maaA-4ui9M:
undetectable
1maaA-4ui9M:
8.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3CE6_D_ADND500_2
(ADENOSYLHOMOCYSTEINA
SE)
4ui9 ANAPHASE-PROMOTING
COMPLEX SUBUNIT 2

(Homo
sapiens)
4 / 5 LEU N 428
GLN N 437
THR N 434
LEU N 386
None
1.22A 3ce6D-4ui9N:
undetectable
3ce6D-4ui9N:
20.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OND_A_ADNA506_2
(ADENOSYLHOMOCYSTEINA
SE)
4ui9 ANAPHASE-PROMOTING
COMPLEX SUBUNIT 2

(Homo
sapiens)
3 / 3 GLN N 437
THR N 434
LEU N 386
None
0.69A 3ondA-4ui9N:
undetectable
3ondA-4ui9N:
20.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OND_B_ADNB507_2
(ADENOSYLHOMOCYSTEINA
SE)
4ui9 ANAPHASE-PROMOTING
COMPLEX SUBUNIT 2

(Homo
sapiens)
3 / 3 GLN N 437
THR N 434
LEU N 386
None
0.68A 3ondB-4ui9N:
undetectable
3ondB-4ui9N:
20.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SM2_A_478A126_2
(GAG-PRO-POL
POLYPROTEIN)
4ui9 ANAPHASE-PROMOTING
COMPLEX SUBUNIT 13
CELL DIVISION CYCLE
PROTEIN 23 HOMOLOG

(Homo
sapiens)
5 / 11 VAL C 336
GLY C 338
ALA C 350
LEU C 319
PRO M  25
None
1.02A 3sm2B-4ui9C:
undetectable
3sm2B-4ui9C:
12.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4AWU_A_4CHA503_0
(OXIDOREDUCTASE,
FMN-BINDING)
4ui9 CELL DIVISION CYCLE
PROTEIN 23 HOMOLOG

(Homo
sapiens)
4 / 6 SER C  51
TYR C 173
PHE C 170
PHE C 116
None
1.32A 4awuA-4ui9C:
undetectable
4awuA-4ui9C:
20.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JX1_E_CAME502_0
(CAMPHOR
5-MONOOXYGENASE)
4ui9 CELL DIVISION CYCLE
PROTEIN 23 HOMOLOG

(Homo
sapiens)
4 / 5 PHE C  94
TYR C 120
THR C  43
PHE C 116
None
1.01A 4jx1E-4ui9C:
undetectable
4jx1E-4ui9C:
19.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4L4B_A_CAMA502_0
(CAMPHOR
5-MONOOXYGENASE)
4ui9 ANAPHASE-PROMOTING
COMPLEX SUBUNIT 11
ANAPHASE-PROMOTING
COMPLEX SUBUNIT 2

(Homo
sapiens;
Homo
sapiens)
4 / 8 LEU N 705
VAL N 704
VAL B   3
VAL N 648
None
1.06A 4l4bA-4ui9N:
undetectable
4l4bA-4ui9N:
20.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YB6_A_HISA302_0
(ATP
PHOSPHORIBOSYLTRANSF
ERASE)
4ui9 CELL DIVISION CYCLE
PROTEIN 23 HOMOLOG

(Homo
sapiens)
5 / 10 GLY C 176
VAL C 177
GLU C 208
VAL C 178
LEU C 212
None
1.18A 4yb6A-4ui9C:
undetectable
4yb6E-4ui9C:
undetectable
4yb6A-4ui9C:
21.39
4yb6E-4ui9C:
21.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YB6_B_HISB302_0
(ATP
PHOSPHORIBOSYLTRANSF
ERASE)
4ui9 CELL DIVISION CYCLE
PROTEIN 23 HOMOLOG

(Homo
sapiens)
5 / 10 GLY C 176
VAL C 177
GLU C 208
VAL C 178
LEU C 212
None
1.19A 4yb6B-4ui9C:
undetectable
4yb6C-4ui9C:
undetectable
4yb6B-4ui9C:
21.39
4yb6C-4ui9C:
21.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YB6_F_HISF302_0
(ATP
PHOSPHORIBOSYLTRANSF
ERASE)
4ui9 CELL DIVISION CYCLE
PROTEIN 23 HOMOLOG

(Homo
sapiens)
5 / 10 LEU C 212
GLY C 176
VAL C 177
GLU C 208
VAL C 178
None
1.19A 4yb6B-4ui9C:
undetectable
4yb6F-4ui9C:
undetectable
4yb6B-4ui9C:
21.39
4yb6F-4ui9C:
21.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5DLV_B_5D5B927_1
(ECTONUCLEOTIDE
PYROPHOSPHATASE/PHOS
PHODIESTERASE FAMILY
MEMBER 2)
4ui9 CELL DIVISION CYCLE
PROTEIN 23 HOMOLOG

(Homo
sapiens)
4 / 7 SER C 304
TYR C 308
HIS C 347
TYR C 364
None
1.50A 5dlvB-4ui9C:
undetectable
5dlvB-4ui9C:
19.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MUG_A_VIVA301_1
(ALPHA-TOCOPHEROL
TRANSFER PROTEIN)
4ui9 CELL DIVISION CYCLE
PROTEIN 23 HOMOLOG

(Homo
sapiens)
3 / 3 SER C  51
SER C  55
PHE C 170
None
0.93A 5mugA-4ui9C:
undetectable
5mugA-4ui9C:
17.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MVM_B_PFLB510_1
(PROTON-GATED ION
CHANNEL)
4ui9 CELL DIVISION CYCLE
PROTEIN 23 HOMOLOG

(Homo
sapiens)
4 / 6 ILE C 244
ALA C 247
LEU C 248
ILE C 269
None
0.84A 5mvmB-4ui9C:
2.5
5mvmC-4ui9C:
2.5
5mvmB-4ui9C:
9.72
5mvmC-4ui9C:
9.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5OM2_B_DXTB501_1
(ALPHA-1-ANTICHYMOTRY
PSIN)
4ui9 CELL DIVISION CYCLE
PROTEIN 23 HOMOLOG

(Homo
sapiens)
5 / 9 LEU C 405
ALA C 401
ASP C 398
HIS C 390
ILE C 385
None
1.16A 5om2A-4ui9C:
undetectable
5om2B-4ui9C:
undetectable
5om2A-4ui9C:
9.20
5om2B-4ui9C:
6.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5X80_C_SALC201_1
(UNCHARACTERIZED
HTH-TYPE
TRANSCRIPTIONAL
REGULATOR RV2887)
4ui9 CELL DIVISION CYCLE
PROTEIN 23 HOMOLOG

(Homo
sapiens)
4 / 7 VAL C 191
VAL C 198
GLY C 171
TYR C 173
None
0.86A 5x80C-4ui9C:
undetectable
5x80D-4ui9C:
undetectable
5x80C-4ui9C:
13.90
5x80D-4ui9C:
13.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YF0_A_SAMA505_0
(CARNOSINE
N-METHYLTRANSFERASE)
4ui9 ANAPHASE-PROMOTING
COMPLEX SUBUNIT 11
ANAPHASE-PROMOTING
COMPLEX SUBUNIT 2

(Homo
sapiens;
Homo
sapiens)
5 / 12 GLY B  32
GLY B  41
ASN B  31
SER N 597
CYH B  34
None
None
None
None
ZN  B 103 (-3.1A)
1.31A 5yf0A-4ui9B:
undetectable
5yf0A-4ui9B:
13.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B89_A_NOVA403_2
(LIPOPOLYSACCHARIDE
EXPORT SYSTEM
ATP-BINDING PROTEIN
LPTB)
4ui9 CELL DIVISION CYCLE
PROTEIN 23 HOMOLOG

(Homo
sapiens)
4 / 6 PHE C 513
ARG C 514
LEU C 516
GLN C 518
None
1.08A 6b89B-4ui9C:
undetectable
6b89B-4ui9C:
9.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6MB9_D_NMYD302_0
(AAC(3)-IIIB PROTEIN)
4ui9 CELL DIVISION CYCLE
PROTEIN 23 HOMOLOG

(Homo
sapiens)
5 / 10 TYR C 364
ASP C 301
THR C 369
GLY C 338
GLU C 374
None
1.45A 6mb9D-4ui9C:
undetectable
6mb9D-4ui9C:
11.11